- $2.61m
- -$6.09m
Annual income statement for NuCana, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 36.4 | 47.9 | 39.1 | 32.8 | 22.8 |
| Operating Profit | -36.4 | -47.9 | -39.1 | -32.8 | -22.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -36.2 | -47.8 | -38.5 | -32 | -22.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -30.7 | -40.5 | -32 | -27.6 | -19 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -30.7 | -40.5 | -32 | -27.6 | -19 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -30.7 | -40.5 | -32 | -27.6 | -19 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -20.2 | -18.6 | -15.2 | -13 | -0.256 |